N-Methyl-3,4-methylenedioxyamphetamine
"N-Methyl-3,4-methylenedioxyamphetamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
Descriptor ID |
D018817
|
MeSH Number(s) |
D02.092.471.683.152.670
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "N-Methyl-3,4-methylenedioxyamphetamine".
Below are MeSH descriptors whose meaning is more specific than "N-Methyl-3,4-methylenedioxyamphetamine".
This graph shows the total number of publications written about "N-Methyl-3,4-methylenedioxyamphetamine" by people in this website by year, and whether "N-Methyl-3,4-methylenedioxyamphetamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2005 | 2 | 1 | 3 |
2006 | 3 | 0 | 3 |
2007 | 2 | 1 | 3 |
2008 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2010 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "N-Methyl-3,4-methylenedioxyamphetamine" by people in Profiles.
-
Acute ascending aortic dissection after MDMA/ecstasy use: A case report. Hellenic J Cardiol. 2016 Sep - Oct; 57(5):351-354.
-
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addict Biol. 2010 Jul; 15(3):365-7.
-
MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity. Brain Res. 2009 Dec 11; 1302:175-82.
-
Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13; 33(8):1484-90.
-
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. J Psychopharmacol. 2008 Mar; 22(2):187-202.
-
A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 2008 Jan 24; 151(2):533-43.
-
Diffusion tensor imaging in MDMA users and controls: association with decision making. Am J Drug Alcohol Abuse. 2007; 33(6):777-89.
-
Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. Am J Drug Alcohol Abuse. 2007; 33(6):765-7.
-
MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl). 2007 Jan; 189(4):531-7.
-
Impulsivity and BOLD fMRI activation in MDMA users and healthy control subjects. Psychiatry Res. 2006 Oct 30; 147(2-3):239-42.